TransMedics Group
(NASDAQ) TMDX
TransMedics Group Financials at a Glance
Market Cap
$3.45B
Revenue (TTM)
$605.49M
Net Income (TTM)
$190.29M
EPS (TTM)
$4.86
P/E Ratio
20.73
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Price
$100.67
Volume
20,699
Open
$97.50
Price
$100.67
Volume
20,699
Open
$97.50
Previous Close
$100.67
Daily Range
$96.50 - $101.58
52-Week Range
$62.23 - $156.00
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Price
$100.67
Volume
20,699
Open
$97.50
Previous Close
$100.67
Daily Range
$96.50 - $101.58
52-Week Range
$62.23 - $156.00
TMDX News
TMDX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout TransMedics Group
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
898
CEO
Waleed H. Hassanein, MD
Website
www.transmedics.comHeadquarters
Andover, MA 01810, US
TMDX Financials
Key Financial Metrics (TTM)
Gross Margin
60%
Operating Margin
18%
Net Income Margin
31%
Return on Equity
54%
Return on Capital
11%
Return on Assets
18%
Earnings Yield
4.82%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.45B
Shares Outstanding
34.30M
Volume
20.70K
Short Interest
0.00%
Avg. Volume
886.31K
Financials (TTM)
Gross Profit
$362.81M
Operating Income
$108.58M
EBITDA
$148.49M
Operating Cash Flow
$192.84M
Capital Expenditure
$59.25M
Free Cash Flow
$133.59M
Cash & ST Invst.
$488.37M
Total Debt
$469.69M
TransMedics Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$160.76M
+32.2%
Gross Profit
$93.41M
+29.7%
Gross Margin
58.11%
N/A
Market Cap
$3.45B
N/A
Market Cap/Employee
$4.74M
N/A
Employees
728
N/A
Net Income
$105.38M
+1436.9%
EBITDA
$32.45M
+99.8%
Quarterly Fundamentals
Net Cash
$18.68M
+110.3%
Accounts Receivable
$84.28M
-13.8%
Inventory
$48.88M
+5.0%
Long Term Debt
$456.38M
-11.5%
Short Term Debt
$13.31M
+388.1%
Return on Assets
17.81%
N/A
Return on Invested Capital
11.09%
N/A
Free Cash Flow
$19.00M
+213.7%
Operating Cash Flow
$34.51M
+75.5%